Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
GSK4527226 for Early Alzheimer's Disease
Recruiting0 awardsPhase 2
Verdun, Quebec
This trial will study if a new drug is safe and effective in people with early Alzheimer's, including mild cognitive impairment and mild dementia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.